FDA Adverse Event Injury Summary report: N

PRODIGY AUTOCODE

MDR report key: 6043075 · Received October 20, 2016

Report

Report Number
3005862821-2016-00089
Event Type
Injury
Date Received
October 20, 2016
Date of Event
September 21, 2016
Report Date
September 21, 2016
Manufacturer
OK BIOTECH CO., LTD.
Product Code
NBW
PMA / PMN Number
K073118
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
MS, US
Reporter Occupation
OTHER

Narratives

Additional Manufacturer Narrative · 1

SUSPECTED DEVICE EVALUATED BY OK BIOTECH AND CALCULATED THAT THE METER OPERATED WITHIN SPECIFICATIONS. THE STANDBY CURRENT TEST IS 12.5UA. THE CRITERIA IS <55UA. PASS; METER SETTING, AUDIO AND ALL BUTTONS FUNCTION ARE OK; TESTED THE SUSPECTED METER WITH IN HOUSE CONTROL SOLUTION AND RETAIN STRIPS (STRIP LOT NUMBER:D6151130-1). THE CONTROL SOLUTION TESTS FOR LEVEL LOW ARE 60/65 MG/DL, FOR LEVEL HIGH ARE 280/277 MG/DL. THE REQUEST CONTROL SOLUTION RANGES ARE: LEVEL LOW 25~70 MG/DL; LEVEL HIGH 210~310 MG/DL. ALL RESULTS WERE WITHIN THE ACCEPTANCE RANGE. PASS; TESTED THE RETURNED STRIPS FROM PATIENTS (STRIP LOT NUMBER:D6151130-1). THE CONTROL SOLUTION TESTS FOR LEVEL LOW WERE 67/65 MG/DL; FOR LEVEL HIGH WERE 272/278 MG/DL. THE REQUEST CONTROL SOLUTION RANGES ARE: LEVEL LOW 25~70 MG/DL; LEVEL HIGH 210~310 MG/DL. ALL RESULTS WERE WITHIN THE ACCEPTANCE RANGE. PASS

Description of Event or Problem · 1

END USER REPORTED THAT MEDICAL ATTENTION WAS SOUGHT ON (B)(6) 2016 AT 1:45 PM AFTER HAVING CONTINOUS HIGH GLUCOSE READINGS (200 - 263 MG/DL) FROM THE PRODIGY METER. THE END USER VISITED THE ER AND COULD NOT RECALL HER BLOOD GLUCOSE READING UPON ARRIVAL. NO INFORMATION WAS PROVIDED IN REGARDS TO TREATMENT ADMINISTERED TO LOWER HER BLOOD GLUCOSE. THE ER DOCTOR INSTRUCTED THE END USER TO FOLLOW UP WITH HER PCP AND TO PURCHASE ANOTHER METER BECAUSE OF THE HIGH READINGS. NO OTHER INFORMATION WAS PROVIDED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
695270 PRODIGY AUTOCODE BLOOD GLUCOSE MONITORING DEVICE NBW OK BIOTECH CO., LTD. 51900 D6151130-1

Patients

Seq Age Sex Outcome Treatment
1 84 YR Required Intervention ACEPRIL 10MG 1 A DAY| DULOXETINE 60MG 1A DAY| GABAPENTIN 100MG 1 A DAY| LEVEMIR 60UNITS 1 A DAY| NAPROXEN 375MG AS NEEDED